AbbVie, Inc. (ABBV)
198.71
-2.24
(-1.11%)
USD |
NYSE |
Apr 24, 16:00
197.73
-0.98
(-0.49%)
Pre-Market: 08:47
AbbVie Total Liabilities (Quarterly) : 137.19B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 81.93B |
| Biogen, Inc. | 11.18B |
| Gilead Sciences, Inc. | 36.40B |
| Johnson & Johnson | 119.71B |
| Regeneron Pharmaceuticals, Inc. | 9.302B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 133.96B |
| Shareholders Equity (Quarterly) | -3.27B |
| Debt to Equity Ratio | -20.85 |
| Current Ratio | 0.6713 |
| Net Debt Paydown Yield | 0.14% |